Physician profile
Jerry Sheen
NPI 1851344915
$5,851.94
in general payments reported to CMS, 2019-2025
31 companies · $612 in 2025
The $612 reported for 2025 was more than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,399 · 2020: $481 · 2021: $584 · 2022: $701 · 2023: $703 · 2024: $1,371 · 2025: $612.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,441 · Long Term Medical Supply Or Device Loan: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,441.18 |
| Long Term Medical Supply Or Device Loan | $245.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,191.92 | 2019-2025 | Affinity, Apligraf, Puraply Wound Matrix |
| Kci USA, INC. | $687.56 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $663.80 | 2019-2025 | Nuzyra |
| Smith+Nephew, INC. | $591.36 | 2019-2025 | Collagenase Santyl, Renasys Go V2 Home, Regranex |
| Musculoskeletal Transplant Foundation INC. | $411.11 | 2019-2025 | |
| Integra Lifesciences Corporation | $399.63 | 2019-2024 | Acell, Tcc-Ez, Integra |
| Urgo Medical North America, LLC | $316.81 | 2024-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Merck Sharp & Dohme LLC | $254.95 | 2019-2024 | Dificid, Zerbaxa, Recarbrio |
| Allergan, INC. | $233.72 | 2019-2020 | |
| Kerecis Limited | $176.84 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Convatec INC. | $152.03 | 2022-2024 | |
| Abbvie INC. | $134.50 | 2021-2024 | Dalvance |
| Cardiovascular Systems INC. | $81.97 | 2021 | |
| Aroa Biosurgery Incorporated | $72.77 | 2019-2025 | |
| Viiv Healthcare Company | $71.11 | 2023-2024 | Dovato |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $65.58 | 2021 | |
| Hartmann USA, INC. | $48.83 | 2022-2025 | Collasorb 1g Powder, Zetuvit Plus |
| Cashflow Solutions, LLC | $42.01 | 2024-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Next Science LLC | $38.23 | 2022-2023 | Surgx, Blastx, Xperience |
| Advanced Oxygen Therapy INC. | $33.73 | 2023 | Topical Oxygen Chamber For Extremities |
| Bioventus LLC | $23.22 | 2022 | |
| Medline Industries LP | $21.90 | 2021 | |
| Solventum Corporation | $18.48 | 2025 | Promogran Prisma, Activ.A.C. |
| Osiris Therapeutics INC. | $17.71 | 2019 | |
| Reapplix INC. | $17.48 | 2024 | 3c Patch Kit - Box |
| Tactile Systems Technology INC | $17.36 | 2023 | Entre Plus, Flexitouch Plus |
| Insmed, INC. | $16.42 | 2025 | Arikayce |
| Royal Biologics, INC. | $15.03 | 2021 | |
| Boston Scientific Corporation | $14.45 | 2022 | |
| Ovik Health, LLC | $13.96 | 2024 | Coflex Tlc |
| Reprise Biomedical, INC. | $7.47 | 2025 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Sheen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.